Sermonix to Host Virtual Clinical Update on its ELAINE Phase 2 Clinical Programs
COLUMBUS, Ohio, June 09, 2022 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat…